Acadia Pharmaceuticals Inc
ACAD
Market Cap$2.69B
Close$
$18.95
10.8% upside
Current Fair Value
10.8% upsideUndervalued by 10.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.69 Billion |
|---|---|
| Enterprise Value | $2.25 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.37 |
| Beta | 0.0 |
| Outstanding Shares | 164,771,521 |
| Avg 30 Day Volume | 1,423,193 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -43.85 |
|---|---|
| PEG | 20.91 |
| Price to Sales | 4.28 |
| Price to Book Ratio | 8.55 |
| Enterprise Value to Revenue | 3.1 |
| Enterprise Value to EBIT | -30.64 |
| Enterprise Value to Net Income | -37 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Acadia Pharmaceuticals Inc
CEO: Uli Hacksell